Pricing Log in Create free account

Virax Biolabs Group Limited (VRAX) vs XORTX Therapeutics Inc. (XRTX)

Virax Biolabs Group Limited and XORTX Therapeutics Inc. are both Biotechnology companies. Virax Biolabs Group Limited and XORTX Therapeutics Inc. are of similar size ($1.7M and $1.6M). Across the 9 metrics below, Virax Biolabs Group Limited leads on 6 and XORTX Therapeutics Inc. on 3.

Valuation

Metric VRAX XRTX Biotechnology median
P/E n/m n/m 10.60
P/S — n/m 9.40
P/B n/m 0.26 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.86 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (642.17%) (303.33%) (32.88%)
Free cash flow yield 0.00% (362.74%) (23.13%)

Profitability

Metric VRAX XRTX Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (99.24%) (51.96%)
Return on assets 0.00% (83.78%) (46.06%)
Return on invested capital 0.00% (54.27%) 0.00%

Growth

Metric VRAX XRTX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 68.79% 51.30% 29.88%
Revenue growth, 5-year CAGR (36.88%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric VRAX XRTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.97 3.59 4.97
Net debt to EBITDA 1.08 0.28 1.01

Dividend

Metric VRAX XRTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric VRAX XRTX Biotechnology median
Market cap 1.58m 1.67m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack